[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-LENZ":3,"homepage-market-summary":29,"stock-news-LENZ":171},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"LENZ","2026-10-05",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"LENZ Therapeutics, Inc. Common Stock","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.","152","Solana Beach, CA",false,{"close":16,"open":17,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":18,"avg_volume_52w":26,"range_52w_percent":27,"record_count":28},3.59,3.6,3.455,3.58,0.01,0.28,777355.514286,6017,3.526,49.25,990585.3012104422,0.3,1325,{"status":30,"indices":31,"watchlist":74,"sectors":96,"benchmarks":151},"success",[32,40,47,54,61,67],{"symbol":33,"name":34,"price":35,"change":36,"pct_change":37,"is_up":38,"sparkline":39,"date":5},"SPX","S&P 500",7773.95,51.23,0.66,true,"0.0,8.3 2.3,10.7 4.6,13.5 6.9,9.4 9.3,11.7 11.6,13.9 13.9,16.0 16.2,10.6 18.5,9.8 20.8,2.6 23.2,2.6 25.5,6.3 27.8,6.4 30.1,3.9 32.4,7.7 34.7,8.5 37.1,9.7 39.4,8.8 41.7,5.2 44.0,2.0",{"symbol":41,"name":42,"price":43,"change":44,"pct_change":45,"is_up":38,"sparkline":46,"date":5},"NDX","NASDAQ 100",31076.44,268.51,0.87,"0.0,12.3 2.3,12.8 4.6,14.9 6.9,13.2 9.3,14.8 11.6,16.0 13.9,16.0 16.2,12.7 18.5,11.4 20.8,5.9 23.2,4.3 25.5,6.0 27.8,5.9 30.1,5.1 32.4,7.2 34.7,6.8 37.1,6.4 39.4,5.8 41.7,3.8 44.0,2.0",{"symbol":48,"name":49,"price":50,"change":51,"pct_change":52,"is_up":38,"sparkline":53,"date":5},"DJI","DOW JONES",51268,91,0.18,"0.0,2.0 2.3,5.0 4.6,7.4 6.9,3.6 9.3,4.7 11.6,7.2 13.9,11.9 16.2,9.5 18.5,10.2 20.8,7.5 23.2,8.9 25.5,11.5 27.8,12.7 30.1,9.1 32.4,11.7 34.7,12.7 37.1,16.0 39.4,15.8 41.7,14.0 44.0,13.3",{"symbol":55,"name":56,"price":57,"change":58,"pct_change":59,"is_up":38,"sparkline":60,"date":5},"COMP","NASDAQ Composite",27477.31,286.45,1.05,"0.0,11.9 2.3,13.4 4.6,15.0 6.9,12.7 9.3,14.1 11.6,16.0 13.9,16.0 16.2,11.9 18.5,10.9 20.8,5.3 23.2,4.2 25.5,7.1 27.8,7.0 30.1,5.8 32.4,8.1 34.7,8.3 37.1,7.8 39.4,7.7 41.7,4.7 44.0,2.0",{"symbol":62,"name":63,"price":64,"change":65,"pct_change":37,"is_up":38,"sparkline":66,"date":5},"RUT","RUSSELL 2000",2833.8,18.6,"0.0,2.0 2.3,5.4 4.6,7.8 6.9,6.8 9.3,8.3 11.6,10.0 13.9,11.0 16.2,9.7 18.5,10.8 20.8,9.6 23.2,8.2 25.5,12.6 27.8,12.9 30.1,12.6 32.4,14.2 34.7,15.1 37.1,16.0 39.4,15.1 41.7,13.0 44.0,11.4",{"symbol":68,"name":69,"price":70,"change":71,"pct_change":72,"is_up":38,"sparkline":73,"date":5},"VIX","CBOE VIX",15.52,0.21,1.37,"0.0,10.2 2.3,7.3 4.6,2.0 6.9,9.7 9.3,4.9 11.6,4.5 13.9,2.5 16.2,11.3 18.5,13.7 20.8,13.5 23.2,16.0 25.5,12.3 27.8,10.4 30.1,13.5 32.4,8.8 34.7,8.9 37.1,7.8 39.4,7.6 41.7,11.8 44.0,10.9",[75,82,89],{"symbol":76,"name":77,"price":78,"change":79,"pct_change":80,"is_up":38,"sparkline":81,"date":5},"NVDA","NVIDIA Corp",238.9,4.95,2.12,"0.0,16.0 7.3,12.2 14.7,13.8 22.0,12.6 29.3,10.1 36.7,7.0 44.0,2.0",{"symbol":83,"name":84,"price":85,"change":86,"pct_change":87,"is_up":14,"sparkline":88,"date":5},"AAPL","Apple Inc",332.89,-0.8,-0.24,"0.0,2.0 7.3,5.2 14.7,16.0 22.0,11.7 29.3,14.9 36.7,10.9 44.0,11.8",{"symbol":90,"name":91,"price":92,"change":93,"pct_change":94,"is_up":38,"sparkline":95,"date":5},"TSLA","Tesla Inc",378.69,8.1,2.18,"0.0,5.6 7.3,13.5 14.7,16.0 22.0,14.9 29.3,15.3 36.7,6.4 44.0,2.0",[97,102,107,112,117,122,127,132,137,142,146],{"name":98,"etf":99,"change":100,"price":101,"is_up":38},"Technology","XLK",0.56,200.93,{"name":103,"etf":104,"change":105,"price":106,"is_up":38},"Financials","XLF",0.73,53.88,{"name":108,"etf":109,"change":110,"price":111,"is_up":38},"Healthcare","XLV",0.72,167.37,{"name":113,"etf":114,"change":115,"price":116,"is_up":38},"Consumer Cycl","XLY",0.35,110.42,{"name":118,"etf":119,"change":120,"price":121,"is_up":38},"Consumer Staples","XLP",0.63,81.04,{"name":123,"etf":124,"change":125,"price":126,"is_up":38},"Energy","XLE",0.99,63.44,{"name":128,"etf":129,"change":130,"price":131,"is_up":38},"Industrials","XLI",0.09,170.1,{"name":133,"etf":134,"change":135,"price":136,"is_up":38},"Materials","XLB",1.31,49.5,{"name":138,"etf":139,"change":140,"price":141,"is_up":14},"Real Estate","XLRE",-0.34,40.67,{"name":143,"etf":144,"change":115,"price":145,"is_up":38},"Utilities","XLU",39.97,{"name":147,"etf":148,"change":149,"price":150,"is_up":38},"Comm Services","XLC",1.17,111.61,[152,157,162,167],{"ticker":153,"name":154,"price":155,"change":156,"is_up":38},"SPY","SPDR S&P 500 ETF",774.83,0.67,{"ticker":158,"name":159,"price":160,"change":161,"is_up":38},"QQQ","Invesco QQQ Trust",756.2,0.88,{"ticker":163,"name":164,"price":165,"change":166,"is_up":38},"DIA","SPDR Dow Jones ETF",512.11,0.2,{"ticker":168,"name":169,"price":170,"change":37,"is_up":38},"IWM","iShares Russell 2000",283.39,{"ticker":4,"count":172,"articles":173},20,[174,180,185,191,197,203,209,213,219,225,230,235,240,245,250,255,260,265,270,275],{"title":175,"link":176,"pubDate":177,"description":178,"source":179},"Shirley L. Lenz Obituary Sep 25, 2026 - Cataldo Funeral Home","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMia0FVX3lxTE9PQm0zclZtZmVHUzQ3TldKeXczcjljNVF5VksyZEFOQmJMT05DYzhYTlhzcjdJcXBSS2RqdEZmUWFJOXdwc2NySVJTZU1pXzJsWkg1UnNyME8wbDZyOTFadWY1dXVfWXdWS1k0?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","Shirley L. Lenz Obituary Sep 25, 2026 Cataldo Funeral Home","Cataldo Funeral Home",{"title":181,"link":182,"pubDate":177,"description":183,"source":184},"LENZ Therapeutics: Below Cash For A Reason (NASDAQ:LENZ) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMihwFBVV95cUxOQlRUUGRQSmhKcWRjMU9ZSlZrVjRsSEFuaklLd3l1VDVSbS1BaTQtRnliVDlydktSWkdCUWJOb0pteHV0eUFrZWdPcDhmV21pVThlZ2NKVks1WG5mSlRHWVlqa3BCQjRYZmFlX1VDbkQyTEkxdDVCWnBWNGFPeTZPZ3ZXOGZYaEU?oc=5","LENZ Therapeutics: Below Cash For A Reason (NASDAQ:LENZ) Seeking Alpha","Seeking Alpha",{"title":186,"link":187,"pubDate":188,"description":189,"source":190},"LENZ Dec 2027 2.500 call (LENZ271217C00002500) stock price, news, quote and history - Yahoo Finance UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZkFVX3lxTFBCNVNwNmJBNjEzNllYSlFTWG1uZ3ZMVnd5RUxYOU9aS3lOTC11Z2M0ZktZR2tDX2dtQ3IzZGlJcDNhNHlqQ0gxMV9oQkZZbVZuX3REbnZ5V2lGX28zSFo4dXFyeUxwZw?oc=5","Mon, 05 Oct 2026 01:21:07 GMT","LENZ Dec 2027 2.500 call (LENZ271217C00002500) stock price, news, quote and history Yahoo Finance UK","Yahoo Finance UK",{"title":192,"link":193,"pubDate":194,"description":195,"source":196},"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ - PR Newswire","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi9wFBVV95cUxNME5oaEZYTmZ0dVg2OG9oM1NRYVdWT2ZmYTkwWnduWXFwV2s2c1VNYzVKOGU2RFVUeTEtOU1FTFZSaVEwTnRWMHVTc2prRVNJRU5wTzRoXzVhVVU5NGpEN0tXZXlLWkdTZkp3aWhiQXh3azg2NWVNd2J4ajRDcHNwckpBNkUxRzNOQ0tzY3llODFRZEFvajhoS2t2aVVUd2pVczIxT0o2UGtRdVZLRHcyQ2NTNE5HeG5kZEgtSU9KRFFRM25va0dxSkx3bDZQQjROYVdEQ3RTdzZKdFRCbGl1akNJVVd2YzJaSk96dUJLcmpqN2tnaUVr?oc=5","Thu, 24 Sep 2026 21:34:00 GMT","INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ PR Newswire","PR Newswire",{"title":198,"link":199,"pubDate":200,"description":201,"source":202},"Gene editing stocks fall after Anthropic’s CRISPR-like discovery - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixgFBVV95cUxOTDVRamdPWHdONW1tQ1oxOE5ra3BYTXdGTTA2V0N5RHgtMl9rUTNVR0ZEN3RhVFFZdHkzSVVManc3eFJBMFJZV3FzVTVlWFZGRjFCeF9zRkFQbGlfd0RXeFlsMEw0Z1Nxc2F0MzR2X0V4dnFCMXdISUlKbmt2cXo0aEZJcXFZZ3FIN0FMOUlJUkpoZmYxbXFhVW9KTGhfTXBqRUtjMkdJZng3RkotcXdPdFh5WHE3Vm8zbjFldnlvOW4xZGNXSVE?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","Gene editing stocks fall after Anthropic’s CRISPR-like discovery TradingView","TradingView",{"title":204,"link":205,"pubDate":206,"description":207,"source":208},"LENZ Oct 2026 17.500 call (LENZ261016C00017500) stock price, news, quote and history - Yahoo Finance Australia","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZkFVX3lxTE5rY2dtVmJCcUhqa2taREtQVXJXY2s2SWwyaTBqVGZkVHAteWxRWjdwOFoxdTJNUWxFRTNNcmZYOTA2c1l5V19SOGE3dkZEVUlOQ1lDbG4xbF8xLWlMSEV0U0gtZHZ0dw?oc=5","Sun, 04 Oct 2026 01:07:58 GMT","LENZ Oct 2026 17.500 call (LENZ261016C00017500) stock price, news, quote and history Yahoo Finance Australia","Yahoo Finance Australia",{"title":210,"link":211,"pubDate":200,"description":212,"source":184},"Gene editing stocks fall after Anthropic’s CRISPR-like discovery - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimgFBVV95cUxOY1lTUGRabXF1anFYVnFxUXpGOHdlNUlGNHltSEtBWVRqa2dTMW85Z05FZ0xhdzJ3bXdQQV9FRERZYnJFX0VtYVFBTnhQemtLYklYQk1GTG9PcHpBMExuYmkySlhMNmFhNzVzZXBWbWFweDlqN2JFamVzTjVuemR2U1RpNGN1RHJXaVZDNHl4RVFocklaR0ZuN1N3?oc=5","Gene editing stocks fall after Anthropic’s CRISPR-like discovery Seeking Alpha",{"title":214,"link":215,"pubDate":216,"description":217,"source":218},"JAGU Should I Buy - Intellectia AI","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiXkFVX3lxTE9TeDUwaG5KMjRMbGY2LWhLUjBraEJsMkIzaGxyeDIyV1VVdzhQSWNlR3ZGRFRMVURWRENJdWNlZWcxeUNhd3NuQV84YmdPNUpfaUlnazRBbjlQRURDRnc?oc=5","Sat, 26 Sep 2026 07:00:00 GMT","JAGU Should I Buy Intellectia AI","Intellectia AI",{"title":220,"link":221,"pubDate":222,"description":223,"source":224},"Lenzing's €300 Million Rights Issue Sends Shares to a 52-Week Low as Berenberg Steps Back - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi8gFBVV95cUxQbDlPcmhYc1psZGJUUTVQSE9hTkhEa0JFYUFRN0VlS29RQVVBTEtyNXdMU1luMlVXNzdkdjBrSDVxeE5uZW1HZ2YxSFo1QXlmRURHY3ZLSlhnc0xlZTVSS0dQVTV4MFlDZ09OMTBiN3hDSmVNTWgtQllrbHpqVXpmNjZ2WXVzUk1LckdERzN3VHFjV3g1REs1clM4M0k2UG5fc3R5VDZxemI1aE1iWlFrcF9zUk11cVVzaFMxSUw5VkZOUFg0ZXVwb214YllPa0JWSG14cFVMN21BeGozRjE2NnBfZzgzcmhnejJxVHA0TDlfZw?oc=5","Fri, 02 Oct 2026 11:21:34 GMT","Lenzing's €300 Million Rights Issue Sends Shares to a 52-Week Low as Berenberg Steps Back AD HOC NEWS","AD HOC NEWS",{"title":226,"link":227,"pubDate":228,"description":229,"source":202},"AM Markets Need to Know: F-35 parts end up in Chinese custody, Google nears Gemini 4 launch, and more - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi8wFBVV95cUxNbkotQ25RM0hwYTItbHgwUXlUQ1VqZ1FPYUV3SGtfT3l3SlFEdFBERVQ1RzBZX1Zqc3VfaUlMU3psdkZ5UXhJUTJDU3lRaTJwWS1ndWxDX2Z0X21DaEJHTVdWMGt6SlJCN0RDa2hCMnl4Mm1oNXMzV3NIQThnSTdtLWdnNXlCcE5oSzRxd3QzVFF3Rml1UEdmTzlDZ1FwYlNRNmhFNkZjUzlvOGNMSEVmNXZacHVxMGVxZnBPX1g1LXpLaFFWbXVTMmgtWEZQRWp0RnRJamN5NDdsc3VjaVk3V3pwdFQtRnY0T3NKVnZSdXdjTVE?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","AM Markets Need to Know: F-35 parts end up in Chinese custody, Google nears Gemini 4 launch, and more TradingView",{"title":231,"link":232,"pubDate":233,"description":234,"source":224},"Lenzing's Balance Sheet Gets Its Fix: The €300 Million Question Is What Comes Next - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5wFBVV95cUxNOVFDLVFjZDhCOVFlSDhLSU5fTDI1NHJKU1JmNUJXWmgyd3pVUnZaODNBWF8tVEZ1LWQxZzVfa0NHVEpMUFlDWDdRUzZDbkNDZ1dBM0EtNjY1UVJ3dmtqdjhJN1J6cV9ZYi0zM2hfSm93aVVHbU1hNEZmT0xualZ5bXlLdDZySm9iV1p0N2ppb24zTVhTbDRlUVNXcW54amVqRjNaSkpyYUxhSmJHSVdGM253dWQzMUJtczNuQ0RfZW9BVTg3SUY0NXZQYWtvckIycWhUSGRfVVFQQzJPdWlIVDc3MEhrcWM?oc=5","Sat, 03 Oct 2026 12:50:59 GMT","Lenzing's Balance Sheet Gets Its Fix: The €300 Million Question Is What Comes Next AD HOC NEWS",{"title":236,"link":237,"pubDate":238,"description":239,"source":224},"Lenzing's €300 Million Cash Call: 42.5% Reference Discount Sends Shares to €13.18 - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2AFBVV95cUxNS18tVnozZFo2WGdXSVFBalMxRTlEbVVOb09oMHVldVZ6Y192bl95cjVOTXFvMVN2R2dTeU9ZenhMdTU5Y0tGaE9kdmtLbFVYVWJsd004VUFRTW5sSlcyT3B4R1dGY3dqdWszbXRnMER4Mk9zakZjTHFZVkdmYU91eTNad2NRUndiZm5GNTRrdm4tREFRckd2eXRJc0lkTWFnZFJTY3I5STJGa2ZfV2g4LUpCNHhwcGdIWnVfR2EyOXYtRU5rRFpQMm1iRThGVk8ybEZJVDh5czM?oc=5","Tue, 06 Oct 2026 14:40:39 GMT","Lenzing's €300 Million Cash Call: 42.5% Reference Discount Sends Shares to €13.18 AD HOC NEWS",{"title":241,"link":242,"pubDate":243,"description":244,"source":224},"Lenzing's 10-for-9 Cash Call Kicks Off as Berenberg Cuts Target to €17 - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2AFBVV95cUxQREx1OC0tMFh3MmR6cldlV3FyNERKWFhOZGp4bmxZYi1ER0tXM01YZ3A2UGlGZVJaM1Y5c0Z3TDlqU1dsZjMzdXJnaEFSQnlGVjdlbmk4TDlQbGpodkdwTmUxVWQtb1BmbmI3cjVnczBvOWtpZXRnYmZPRUFyLV9CcWxrY2NYVUJZbzhlRGdkQ0Q5d2YwZ211bU1MRkZoZGpuSmoyZzhadWI0enNLYkJvOFdFUlJkay1lWV9TbF8xdm8zYjhaUUk4UDMxWFA0YjFGeFhwS29pQk0?oc=5","Mon, 05 Oct 2026 16:41:03 GMT","Lenzing's 10-for-9 Cash Call Kicks Off as Berenberg Cuts Target to €17 AD HOC NEWS",{"title":246,"link":247,"pubDate":248,"description":249,"source":224},"Lenzing's €300 Million Rescue Comes With a 42.5% Discount — and a Downgrade - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5gFBVV95cUxNYWZFbnFhOUV4VVRtMlhCcGZ3Qi1qSzUzOVVLNHJseXFZS0VZS2ZoQ3lnU29BZ1dBLWFsM0Z2UlBOTHBnaHFLZkFzQXd0NUdLOXduMDNUTzNGN3NwYl85VFV2SnJhZXVCUnhOZHNIa3RtNU1HdEVSVjVzOC1LaC1Jcmt6M0NmbHBYYndtTzBDQ2NmN0xJVzFnMTFNY3I2VDN4SFNBc195SllkTmpBZDJ0clhIbFNCOW5uVVlfTzgydXBfZFRnaC1tMVRRcmktSGxfaFZZOW9RV0xqN3Viemp3WjBvNS0tdw?oc=5","Sat, 03 Oct 2026 00:50:36 GMT","Lenzing's €300 Million Rescue Comes With a 42.5% Discount — and a Downgrade AD HOC NEWS",{"title":251,"link":252,"pubDate":253,"description":254,"source":224},"Lenzing's Dual Shock: Rights Issue Arithmetic and a Berenberg Downgrade Collide - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5AFBVV95cUxNdXMya3hFeXVzcG43b0NtbVE1dlVqcnBwZWdnU2E0VkxKSU4yNlh4eHBQQ2tQam9QZXpGQlNUeENjWEdNOGVfTVpHRXVzSDZyS19fbmx1SjNoVExGNnpnVUdTZWFoZFIta1RUOElQcVdSTFB4akdQQ05JWE9tWWlIVWdLVkUtc2dHQS1JZVlwdWs2dmVRT1ZfRnZVbDRNYTN6Ul9DU1ZtYldHSWhSWk9sY3FWbXV6UFhVR3JFVDRTVGNpUXVBTXFERGRkYnptdkFyaXFEdzR5QnJaWnY1aWo0ZnhNS3c?oc=5","Sat, 03 Oct 2026 11:01:59 GMT","Lenzing's Dual Shock: Rights Issue Arithmetic and a Berenberg Downgrade Collide AD HOC NEWS",{"title":256,"link":257,"pubDate":258,"description":259,"source":224},"Lenzing's €300 Million Lifeline: Rights Issue Math, a Berenberg Downgrade, and the Fight for 14 Eu - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizAFBVV95cUxNLTRNTFFoUDlidWt0S1A0ZWZONm8xdGxvUW1ZaV83cEhpSGpnOTFmU1hQNTM2N3VkU1oyYzIzS1J3VHRwMG1FNUMxUjAwaEpKNHBoUk5xS2dURE11NEVNZjNWNkROcGdkQm9CVllXMDVBaTRwVWM5OWtyTGRJT1Nnc19rR3lWRTNaNjhSMEtHR1MzbTJhdTRBMWVOdjBsRGJVRmU5a2VsdkkwZkJSUGZDRHdPcVAtZmRVQmlReC1GQlVLUDd6cURodW1Zb0M?oc=5","Sat, 03 Oct 2026 16:40:59 GMT","Lenzing's €300 Million Lifeline: Rights Issue Math, a Berenberg Downgrade, and the Fight for 14 Eu AD HOC NEWS",{"title":261,"link":262,"pubDate":263,"description":264,"source":224},"Lenzing's €300 Million Recapitalisation: A 10-for-9 Rights Issue, a Berenberg Downgrade, and the R - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0gFBVV95cUxQUmlVRERmc0FFTkYzM3V5SzYyMlJ4ODVDZTdWZEZXbTBZR05WTGpQamdqbXFuU2dtN1NRT3NSZWxfXzRMR241VnQ0bkVWZkYxMjNPYWpCUmxfRDV2aUZRd3FGRjMzZ3MxdHVPU1NGOVlCRFJMSlZEc3lrZ1NSX3dHSWQ4TlJfa19WZFVMcTAxbDFmVEF2bXM4dHZtRWhxNXAzcW1KWnQzb090U0tYa041b2s5VjQzZFZBMTM3UThxR1pHVkh3MVl2RnZHNWJpdjZuOEE?oc=5","Sun, 04 Oct 2026 04:41:06 GMT","Lenzing's €300 Million Recapitalisation: A 10-for-9 Rights Issue, a Berenberg Downgrade, and the R AD HOC NEWS",{"title":266,"link":267,"pubDate":268,"description":269,"source":224},"Lenzing's 42.5% Arithmetic Reset: Rights Issue Discount and a Berenberg Downgrade Land on the Same D - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMigAJBVV95cUxOVEFFNC1NUllqS0I5NUJJUHREcFd3aVNGWjR4ZXRPdG5JSTFMVFBUYkhYTnJqVzFWUjFUVGMzdVhaNEFCODZldEs5VEx2NGZzQkhZeU41SWFRMUdEdTVHZHNXdTBvc1JKZHRIWWltWlpIanZMQkpKc1FGbFBKMFFjcXJVRWlQendkZ1Bpc1R6cnkzNnZZNFAtRU1VVXZ3cjFNSHpiQkM5ZkVGaU1hUlNQVHIxQmZncURRWVF4ZmRFXzY0THlJelhQLUROVUIyZktpV1FUQlhUV0FycFVaTFMtZ2R1aWxqWnRNQ2VyWFdqZjd1ZFFmNXU1UzFrQ3BrUk5K?oc=5","Sat, 03 Oct 2026 05:42:21 GMT","Lenzing's 42.5% Arithmetic Reset: Rights Issue Discount and a Berenberg Downgrade Land on the Same D AD HOC NEWS",{"title":271,"link":272,"pubDate":273,"description":274,"source":224},"Lenzing's €300 Million Rights Issue Enters Critical Week as Berenberg Downgrades - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5gFBVV95cUxNay14czdFS05TZVNzSFladXRKemlLMFliQ2xYNlZUdy1NNDYxUmR3dldHS2FnUjVUZnBJZm5ZSkpsb09lbmstOXhfRno5MExaaTNMVFNKV3hjcUdXeUNLQUpXMG9NRGNKT2pJc0Q5SDhaZ1FwSTV3LWhUWl9NNkNpNTI4dkE0LVZ5UWxiTEx2cUd6elkyanROWVVtZmNjX2k0UjRMM3lLRk01c0hqNDliZnFWMjdrYzVFc255Y1JxazRNTjR1RGlBdWJRTnBxN0NHNFFHUDdIOXlpQXZPMEtjZkhBWDN5UQ?oc=5","Mon, 05 Oct 2026 15:10:56 GMT","Lenzing's €300 Million Rights Issue Enters Critical Week as Berenberg Downgrades AD HOC NEWS",{"title":276,"link":277,"pubDate":222,"description":278,"source":224},"Lenzing's 8.65 Euro Subscription Price Triggers Sell-Off as Rights Trading Looms - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5wFBVV95cUxNa0d3X0s5VVBoVXAwN0lVODFMdV9UcXcwRzZZZHNzU0Vic2NSTHQzbTBWckVXUmNWMDRfZFJkRTVvMURsSFQwUVdVYVJsXzNnMUcwUm5XeldJX3ZHS3VaelptRXNTNlY5ejN3WmRYQ1RVMnM3dEV2TnZ1T3VJVFl3S2VlWkx0d1dDTVltcGYtSFR5RHlRQXJ3bmFOR1dwdnMwMHpKYUtIVlhXUnhOeWZMMVRIX01pbF9WVjVYVVpBY21Xd1VyU0pSRjl3T0VCSGtBMlRyamVVMzRyeUlyd19tN0lfUDBMM1E?oc=5","Lenzing's 8.65 Euro Subscription Price Triggers Sell-Off as Rights Trading Looms AD HOC NEWS"]